New Drug CD47 Could Potentially Shrink and Cure All Tumors
New research points that there could be a single drug that could shrink or cure all types of cancer, whether it’s breast, ovary, colon, bladder,…
Cancer
Nanomedicine BIND-014 to Enter Human Clinical Studies
The cancer drug, BIND-014, is the first targeted and programmed nanomedicine to enter human clinical studies. A newly published study demonstrate BIND-014’s ability to effectively…
Custom Tailored Brain Cancer Vaccine Proves Effective
A new vaccine has been found to extend the life of patients suffering from recurrent glioblastoma multiforme. A phase 2 clinical trial showed that by…
Computer Chip-Shaped Neutron Source
Technological advances in the field of neutron generators are being made at Sandia National Laboratory. By thinking outside the box, scientists have come up with…
Protein NLRP12 Protects Against Colon Cancer
A newly published research study from the UNC Lineberger Comprehensive Cancer Center describes how the absence of the protein NLRP12 significantly increases susceptibility to colitis-associated…
Cancer Study Reveals Limitations When Using Angiogenesis Inhibitors and Nanomedicines
A new study suggests that dosage size matters when it comes to treating cancer with angiogenesis inhibitors and nanomedicines. Scientists at the Harvard School of…
Immune System May Trigger Melanoma Growth
Findings suggest that our own immune system may be working against us when it comes to protection from skin cancer. The scientists found that in…
First Volume of the Cancer Cell Line Encyclopedia
Authored by leading scientists at top institutions, the Cancer Cell Line Encyclopedia (CCLE) is a resource that joins deeply detailed cancer genome data with predictors…
Examining the Mechanism Behind Melanoma Drug Resistance
Zelboraf, which targets the mutated BRAF gene, is used to treat melanoma, but it isn’t always successful due to melanoma’s ability to sometimes get around…
Tyrosine Phosphatase SHP2 and Breast Cancer
A new study identified the protein phosphatase SHP2 as an important player in the signaling cascades governing tumor initiating cells. The scientists found that SHP2…
Researchers Use Bioinformatics and Epigenetics to Aid Cancer Research
A computational epigenetics research group at the Max Planck Institute for Informatics in Saarbrücken is using software programs to rummage through the genomes of cancer…
Zelboraf Nearly Doubles Median Survival Time for Patients with Metastatic Melanoma
New research shows that the approved drug Zelboraf nearly doubles the median survival time for patients with metastatic melanoma. By following 132 patients, researchers found…
Microfluidic Device Can Isolate Target Cells Faster than Existing Devices
Researchers at MIT and Massachusetts General Hospital have demonstrated a new microfluidic device that can isolate target cells much faster than existing devices and may…
Researchers Discover Proteins Responsible for Cancer Cell Movement
While observing breast cancers cells in culture, researchers at Cornell University identified two key proteins, Hsp70 and tTG, that are responsible for cell migration. By…
Cancer-Causing Mutations Disrupt Cells’ Ability to Differentiate
Researchers have published a series of three papers today in the journal Nature, explaining some of the mysteries of how the mutations in a gene…
Researchers Use Body’s Immune System to Fight Cancer
New research points suggests that DNA sequences from tumor cells can also be used to direct the body’s immune system to attack cancer cells, according…
Researchers Focus on Using High-Energy Electrons to Treat Cancer
Researchers are working on new technology that could dramatically reduce the time needed for cancer radiation treatments. By using high-energy electrons for radiation therapy, the…
Researchers Use Grape Seed Extract to Kill Cancer Cells
Researchers at the University of Colorado Cancer Center are studying the effect of grape seed extract (GSE) on cancer cells found in the head and…
